N-terminal Pro B-type natriuretic peptide levels in infants and children with acute non-cardiac diseases

Israel Medical Association Journal

Volumn 13, Issue 7, 2011, Pages 420-424

  Nevo, Inbar ^a   Erlichman, Mati ^c   Algur, Nurit ^c   Nir, Amiram ^b  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Acute illness; Children; Fever; Heart disease; Infants; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CARDIOMYOPATHY; CHEMOLUMINESCENCE; CHILD; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEHYDRATION; DISEASE SEVERITY; ENDOCARDITIS; FEMALE; FEVER; GASTROENTERITIS; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HEART TAMPONADE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; OXYGEN SATURATION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT INFECTION; RHEUMATIC FEVER; SEPSIS; TACHYCARDIA; WEIGHT;

ACUTE DISEASE; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; IMMUNOASSAY; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX;

EID: 79960687453     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001; 39 (7): 571-88.
2. Baughman KL. B-type natriuretic peptide-a window to the heart. N Engl J Med 2002; 347 (3): 158-9.
3. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339 (5): 321-8.
4. Gotze JP, Kastrup J. Plasma pro-brain natriuretic peptides are strong biochemical markers in clinical cardiology. Scand J Clin Lab Invest Suppl 2001; 234: 47-51.
5. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002; 105 (5): 595-601.
6. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347 (3): 161-7.
7. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355 (9210): 1126-30.
8. Nakamura T, Sakamoto K, Yamano T, et al. Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 39 (10): 1657-63.
9. Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Pharmacol Ther 2004; 102 (3): 223-41.
10. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003; 107 (20): 2545-7.
11. Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis 2002; 44 (4): 293-321.
12. Fried I, Bar-Oz B, Algur N, et al. Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction. Pediatrics 2006; 118 (4): el 165-8.
13. Nir A, Bar-Oz B, Perles Z, Brooks R, Korach A, Rein AJ. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr 2004; 93 (5): 603-7.
14. Nasser N, Perles Z, Rein AJ, Nir A. NT-pro BNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis. Pediatr Cardiol 2006; 27 (1): 87-90.
15. Nir A, Lindinger A, Rauh M, et al. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009; 30 (1): 3-8.
16. Hammerer-Lercher A, Geiger R, Mair J, et al. Utility of N-terminal pro-B-type natriuretic peptide to differentiate cardiac diseases from noncardiac diseases in young pediatric patients. Clin Chem 2006; 52 (7): 1415-19.
17. Dahdah N, Siles A, Fournier A, et al. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 2009; 30 (6): 810-17.
18. Horwich TB, Hamilton MA, Fonarow GC. B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 2006; 47 (1): 85-90.
19. Krauser DG, Lloyd-Jones DM, Chae CU, et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a proBNP investigation of dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 2005; 149 (4): 744-50.
20. Sarzani R, Dessi-Fulgheri P, Paci VM, Espinosa E, Rappelli A. Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 1996; 19 (9): 581-5.
21. Dessi-Fulgheri P, Sarzani R, Tamburrini P, et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens 1997; 15 (12 Pt 2): 1695-9.